Next-Generation Molecular Residual Disease Assays: Do We Have the Tools to Evaluate Them Properly?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Next-Generation Molecular Residual Disease Assays: Do We Have the Tools to Evaluate Them Properly?

Published:2024-08-10 Issue:23 Volume:42 Page:2736-2740
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Stetson Dan¹^ORCID,Labrousse Paul¹,Russell Hugh¹,Shera David²,Abbosh Chris³,Dougherty Brian¹,Barrett J. Carl¹^ORCID,Hodgson Darren³,Hadfield James⁴^ORCID

Affiliation:

1. Translational Medicine, Oncology R&D, AstraZeneca, Waltham, MA

2. Oncology Biometrics, AstraZeneca, Gaithersburg, MD

3. Cancer Biomarker Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom

4. Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom

Publisher

American Society of Clinical Oncology (ASCO)

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.23.02301

Reference47 articles.

1. Detection and quantification of mutations in the plasma of patients with colorectal tumors

2. Cell-Free DNA in Human Blood Plasma

3. The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

4. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

5. A mathematical model of ctDNA shedding predicts tumor detection size

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to S. Sorscher;Journal of Clinical Oncology;2024-09-11

2. Clinical Utility of Circulating Tumor DNA Assays;Journal of Clinical Oncology;2024-09-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP